Date:
Patient:
Procedure:
Surgical procedure requiring neuromuscular blockade (specify type of surgery if relevant)
Anesthesia Providers:
Attending Anesthesiologist
Resident/CRNA
Neuromuscular Blockade Agent:
Name of medication used
Dose administered
Reversal Agents Used:
Name(s) of reversal medications used (e.g., Neostigmine, Sugammadex)
Dose(s) administered
Time of administration relative to neuromuscular blockade
Reversal Assessment:
Train of four (TOF) count: Monitor recovery of muscle function using a nerve stimulator to assess return of twitches in a specific muscle group (e.g., adductor pollicis).
Document TOF count at specific time points (e.g., every minute) after administration of reversal agents.
Specify criteria used for considering adequate reversal (e.g., TOF ratio > 0.9).
Clinical signs: Assess return of spontaneous respiration, ability to follow commands, and adequate tidal volume.
Response to Reversal:
Describe the time course of TOF count recovery and achievement of adequate reversal criteria.
Note any complications during reversal (e.g., prolonged weakness, fasciculations).
Postoperative Considerations:
Presence of residual weakness and need for monitoring (if any).
Respiratory support weaning plan (if applicable).
Plan:
Continue monitoring respiratory function and muscle strength in recovery until extubation is deemed safe.
Address any residual weakness or complications arising from reversal.
Disclaimer: This information is for educational purposes only and should not be interpreted as medical advice. Please consult with a qualified healthcare professional for specific details and management of neuromuscular blockade reversal.